| 000 | 01807 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517092922.0 | ||
| 264 | 0 | _c20171019 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.1080/21645515.2016.1164362 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Der Meeren, Olivier | |
| 245 | 0 | 0 |
_aProspective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _c08 2016 |
||
| 300 |
_a2197-2203 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xblood |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPeterson, James T | |
| 700 | 1 | _aDionne, Marc | |
| 700 | 1 | _aBeasley, Richard | |
| 700 | 1 | _aEbeling, Peter R | |
| 700 | 1 | _aFerguson, Murdo | |
| 700 | 1 | _aNissen, Michael D | |
| 700 | 1 | _aRheault, Paul | |
| 700 | 1 | _aSimpson, Richard W | |
| 700 | 1 | _aDe Ridder, Marc | |
| 700 | 1 | _aCrasta, Priya D | |
| 700 | 1 | _aMiller, Jacqueline M | |
| 700 | 1 | _aTrofa, Andrew F | |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 12 _gno. 8 _gp. 2197-2203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21645515.2016.1164362 _zAvailable from publisher's website |
| 999 |
_c25967511 _d25967511 |
||